BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 19940275)

  • 1. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
    Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
    Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats.
    Hasegawa Y; Suzuki H; Altay O; Rolland W; Zhang JH
    Transl Stroke Res; 2013 Oct; 4(5):524-32. PubMed ID: 24187597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod provides long-term protection in rodent models of cerebral ischemia.
    Wei Y; Yemisci M; Kim HH; Yung LM; Shin HK; Hwang SK; Guo S; Qin T; Alsharif N; Brinkmann V; Liao JK; Lo EH; Waeber C
    Ann Neurol; 2011 Jan; 69(1):119-29. PubMed ID: 21280082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
    Kraft P; Göb E; Schuhmann MK; Göbel K; Deppermann C; Thielmann I; Herrmann AM; Lorenz K; Brede M; Stoll G; Meuth SG; Nieswandt B; Pfeilschifter W; Kleinschnitz C
    Stroke; 2013 Nov; 44(11):3202-10. PubMed ID: 24029635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in animal models of stroke.
    Liu J; Zhang C; Tao W; Liu M
    Int J Neurosci; 2013 Mar; 123(3):163-9. PubMed ID: 23167788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.
    Yoshino T; Tabunoki H; Sugiyama S; Ishii K; Kim SU; Satoh J
    Cell Mol Neurobiol; 2011 Oct; 31(7):1009-20. PubMed ID: 21519925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of FTY720 against sevoflurane-induced developmental neurotoxicity in rats.
    Zhou H; Li S; Niu X; Wang P; Wang J; Zhang M
    Cell Biochem Biophys; 2013 Nov; 67(2):591-8. PubMed ID: 23471662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.
    Nazari M; Keshavarz S; Rafati A; Namavar MR; Haghani M
    Brain Res Bull; 2016 Jun; 124():95-102. PubMed ID: 27066884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
    Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia.
    Liesz A; Sun L; Zhou W; Schwarting S; Mracsko E; Zorn M; Bauer H; Sommer C; Veltkamp R
    PLoS One; 2011; 6(6):e21312. PubMed ID: 21701599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.
    Slowik A; Schmidt T; Beyer C; Amor S; Clarner T; Kipp M
    Br J Pharmacol; 2015 Jan; 172(1):80-92. PubMed ID: 25220526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model.
    Chen C; Hu Q; Yan J; Lei J; Qin L; Shi X; Luan L; Yang L; Wang K; Han J; Nanda A; Zhou C
    J Neurochem; 2007 Sep; 102(6):1831-1841. PubMed ID: 17532791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.
    Potteck H; Nieuwenhuis B; Lüth A; van der Giet M; Kleuser B
    Cell Physiol Biochem; 2010; 26(1):67-78. PubMed ID: 20502006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
    Hofmann U; Hu K; Walter F; Burkard N; Ertl G; Bauersachs J; Ritter O; Frantz S; Bonz A
    Br J Pharmacol; 2010 Jul; 160(5):1243-51. PubMed ID: 20590616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
    Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
    Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats.
    Yu ZH; Cai M; Xiang J; Zhang ZN; Zhang JS; Song XL; Zhang W; Bao J; Li WW; Cai DF
    J Ethnopharmacol; 2016 Apr; 181():8-19. PubMed ID: 26805466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia.
    Briyal S; Shah S; Gulati A
    Neuroscience; 2014 Dec; 281():269-81. PubMed ID: 25301749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.
    Naseh M; Vatanparast J; Rafati A; Bayat M; Haghani M
    Brain Behav; 2021 Jun; 11(6):e02179. PubMed ID: 33969931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high soy diet reduces programmed cell death and enhances bcl-xL expression in experimental stroke.
    Lovekamp-Swan T; Glendenning M; Schreihofer DA
    Neuroscience; 2007 Sep; 148(3):644-52. PubMed ID: 17706879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.